HOME >> BIOLOGY >> NEWS
Managing occupational exposures to potential bioterrorist agents

Laboratories working with biological threat agents must develop comprehensive programs in order to minimize the risk of occupational exposures, according to investigators at the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID).

In an article published this month in the Journal of Occupational and Environmental Medicine, Janice M. Rusnak, M.D. and colleagues at USAMRIID note that research on agents of bioterrorism is becoming more widespread. At the same time, institutions beginning such work may have limited clinical experience or procedures in place for the medical management of laboratory exposures to these agents. And while information on preventing occupational exposures to high-risk agents is widely available, literature on medical management of these exposures when they do occur is limited.

To assess the effectiveness of the USAMRIID program--and to provide helpful information to other institutions involved in biological threat agent research--Rusnak and her team reviewed potential laboratory exposures at the Institute between 1989 and 2002.

"We chose this time period for two reasons," said Rusnak. "First of all, treatment protocols can change over time, and we wanted this review to contain more recent information in order to be of use to others in the field. Secondly, the data were most consistent during this timeframe. Prior to 1989, the records were kept in a different format."

The review noted only five confirmed laboratory-acquired infections, out of 234 evaluations of potential exposures and illnesses, in a fourteen-year period. These confirmed cases involved glanders, Q fever, vaccinia, chikungunya and Venezuelan equine encephalitis. All five individuals made a full recovery.

According to Rusnak, potential exposures fell mainly into two categories: percutaneous and aerosolized. Percutaneous exposures included events such as needlesticks, cuts, and animal bites or scratches. Aerosolized exp
'"/>

Contact: Caree Vander Linden
Caree.Vander-Linden@amedd.army.mil
301-619-2285
US Army Medical Research Institute of Infectious Diseases
20-Aug-2004


Page: 1 2 3 4

Related biology news :

1. At the waters edge -- Managing riparian forests
2. Managing For Deer, Moose, Elk, Wolves -- And People
3. Five studies look at risks of differing particulate matter, including exposures on 9/11
4. Sex-based differences in environmental exposures and health
5. Award winning researchers reveal potential new role for Glivec
6. Evidence builds for potential new cancer drug target
7. Scientists discover potential new way to control drug-resistant bacteria
8. Tiny molecules have big potential as cancer drugs, Stanford researcher believes
9. OneWorld Health compiles comprehensive state of infectious diarrhea treatments, potential solutions
10. Location of potential familial lung cancer gene discovered
11. Acamprosate: potential medication for treating alcoholism

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/26/2020)... SHANGHAI (PRWEB) , ... August 24, 2020 , ... ... approaches for the treatment of chronic inflammatory and fibrotic diseases, today announced that ... Vice President of Drug Discovery. , Dr. Canan previously served as Executive Director ...
(Date:8/21/2020)... ... August 18, 2020 , ... Sentien Biotechnologies, ... that the U.S. Food and Drug Administration (FDA) has approved the company’s Investigational ... the treatment of severe COVID-19. Approval of this IND allows Sentien to initiate ...
(Date:8/12/2020)... , ... August 12, 2020 , ... ... monitoring systems that are ideal for public health agencies of all sizes. With ... diseases and helping at-risk individuals find appropriate health care, Mosio helps public health ...
Breaking Biology News(10 mins):
(Date:8/3/2020)... ... ... Introducing Ardent Animal Health – MediVet Biologics rebrands company and positions its platform ... Biologics since its formation in 2016, the company is relaunching itself under the Ardent ... its base of innovative therapies for osteoarthritis and cancer. , ...
(Date:7/31/2020)... ... July 29, 2020 , ... G-CON Manufacturing, the ... new tagline, “BUILDING FOR LIFE.” The adoption of this taglines comes at a ... fast track capacity to provide patients with urgently needed vaccines and other lifesaving ...
(Date:7/31/2020)... ... July 29, 2020 , ... Anomet Products has introduced ... materials for use with CRM, neurostimulation, vascular, and related devices. , Anomet ... design requirements, performance, and cost criteria; especially where solid wire is limited. Typical ...
(Date:7/31/2020)... ... July 29, 2020 , ... eSource has long been touted as ... cover the history of eSource, the reasons it did not take off as quickly ... site source, the industry is moving towards capturing data electronically for clinical trials and ...
Breaking Biology Technology:
Cached News: